...olmesartan/hydrochlorothiazide Fixed-dose combination of olmesartan and hydrochlorothiazide, a diuretic Marketed for hypertension Not applicable Tribenzor/Sevikar HCT olmesartan/amlodipine/hydrochlorothiazide...

...diuretic; Azor, a fixed-dose combination of olmesartan and amlodipine, a dihydropyridine calcium channel blocker; and Tribenzor...
.../ Sevikar olmesartan/amlodipine; Benicar /Olmetec olmesartan; Benicar HCT olmesartan/ hydrochlorothiazide; Tribenzor / Sevikar HCT olmesartan/amlodipine/hydrochlorothiazide ( CS-8635...

...Daiichi's Daiichi Sankyo UK unit launched Sevikar HCT in the U.K. to manage hypertension. The fixed-dose combination...
...a dihydropyridine calcium channel blocker, and hydrochlorothiazide, a diuretic, is approved in the U.S. as Tribenzor...

...The Scottish Medicines Consortium recommended the use of Sevikar HCT from Daiichi Sankyo on the National Health...
...approved indication. The drug is approved in the U.S. as Tribenzor to lower blood pressure. Sevikar HCT...
...Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Product: Sevikar HCT ( Tribenzor - U.S.) olmesartan/amlodipine/hydrochlorothiazide ( CS-8635...

...Product: Tribenzor olmesartan/amlodipine/hydrochlorothiazide ( CS-8635 ) Business: Cardiovascular FDA approved an NDA from Daiichi for Tribenzor...
...includes a black box warning stating that patients should discontinue use if they become pregnant. Tribenzor...

...of the Phase III TRINITY trial in 2,492 patients with moderate-to-severe hypertension showed that the olmesartan/amlodipine/hydrochlorothiazide...
...approved for the indication. Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Product: Olmesartan/amlodipine/hydrochlorothiazide ( CS-8635...

...Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568) said olmesartan/amlodipine/hydrochlorothiazide triple combination therapy met the primary endpoint of...